工程红细胞对抗原特异性免疫耐受性和自身免疫性疾病的个性化治疗
Yeshuang Yuan1, Mengfan Yu2, Xingxing Zhu2
1Department of Rheumatology, Beijing Hospital, National Center for Gerontology, Institute of Geriatric Medicine, Clinical Immunology Center, Chinese Academy of Medical Sciences, Beijing 100730, PR China; National Center for Clinical Laboratories, Institute of Geriatric Medicine, Beijing Hospital & National Center of Gerontology, Beijing 100730, China.
概括
研究人员开发了一种新的红细胞 (RBC) 平台,用于治疗自身免疫性疾病. 该平台诱导抗原特异性耐受性,为自身免疫性疾病的广泛免疫抑制提供了一个有希望的替代方案.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 治疗方法 治疗方法
背景情况:
- 目前的自身免疫性疾病疗法使用广泛的免疫抑制剂,导致全身副作用和非目标毒性.
- 一个关键的挑战是实现抗原特异性免疫耐受性,同时保持保护性免疫力.
研究的目的:
- 开发一种基于红细胞 (RBC) 的模块化平台,用于诱导抗原特异性耐受性.
- 在自身免疫性疾病的临床前模型中评估这个平台的有效性.
主要方法:
- 通过通过应变促进的亚酸-基环添加 (SPAAC) 结合与疾病相关的来改造红细胞.
- 在试验室中评估红细胞的生物物理完整性和生物相容性.
- 在实验性自身免疫性脑膜炎 (EAE) 和原诱导性关节炎 (CIA) 模型中测试了工程化红细胞.
- 研究了涉及抗原呈现细胞 (APC) 和T/B细胞反应的机制.
主要成果:
- 工程RBC保持了完整性和生物相容性.
- 在EAE和CIA模型中,结合的红细胞诱导了强大的抗原特异性耐受性和持久的疾病缓解.
- 该机制涉及将APC重新编程为耐受性表型,从而导致T细胞无能化和抑制B细胞激活.
结论:
- 建立了基于红细胞的多功能,临床可翻译的平台,用于抗原特异性自身免疫性疾病治疗.
- 通过诱导耐受性和保持保护性免疫力,证明了个性化治疗的潜力.
相关概念视频
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Antigens Involved in Adaptive Immunity
1.6K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K
Humoral Immune Responses
84.1K
Overview
84.1K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
What is Genetic Engineering?
80.4K
Overview
80.4K
What is the Immune System?
131.2K
Overview
131.2K


